Policy Watch
Refine Results
- view as grid
- view as list
Seeing Others Vaccinated May Be The Best Cure For Vaccine Hesitancy
In his latest Axios column, Drew Altman shows why vaccine hesitancy will naturally decrease as more and more people see their family members and friends vaccinated without adverse consequences. It’s a hopeful sign about vaccine hesitancy, and should help free up resources to focus on the remaining vaccine hesitant.
Perspective Read More
How Quickly We Need To Ramp Up Vaccinations To Get To Herd Immunity
Debate about how many vaccinations are needed by when has been in the news. Drew Altman lays it out in his latest column.
Perspective Read More
We Need a Better Way Of Distributing the COVID-19 Vaccine. Here’s How To Do It.
In an op-ed for The Washington Post, KFF President Drew Altman calls for a simplification of the troubled COVID-19 vaccine distribution system.
Perspective Read More
The Challenge Of Vaccine Hesitancy In Rural America
In his latest Axios column, Drew Altman looks at the challenge of vaccine hesitancy in rural America and its implications. One of them: a highly tailored outreach campaign is needed. “Addressing this hesitancy will require convincing rural Americans about the seriousness of the pandemic, and then that the vaccine is a way to protect them, their families and their way of life,” he said.
Perspective Read More
Joe Biden’s New Health Care Agenda (and CMS’s Big Role In It)
With the Georgia runoff elections giving Democrats control of the U.S. Senate, Drew Altman discusses President-elect Biden’s potential health care agenda and suggests that the Centers for Medicare & Medicaid Services could have an expanded role and that it may be time to rename it and elevate it to a cabinet agency.
Perspective Read More
Real Progress Is Possible On Vaccine Hesitancy
Drew Altman’s Axios column draws on data from the new KFF COVID-19 Vaccine Monitor to assess where the country stands on vaccine hesitancy.
Perspective Read More
COVID-19 Is Causing Health Spending To Go Down
New analysis from Drew Altman in his latest Axios column on the impact of the coronavirus pandemic on national health spending.
Perspective Read More
The Exit Polls Show The Need To Confront COVID-19 Denial in Red America
Drew Altman analyzes the exit polls in his latest Axios column. While Biden voters see COVID-19 as a top priority, Trump supporters are still largely pandemic deniers, echoing the President.
Perspective Read More
Joe Biden’s Big Lead on Health Care Issues
In an Axios column, Drew Altman discusses how this election year health isn’t a single issue — but several — and Joe Biden has the edge over President Trump on all of them, even as opposition to the ACA remains popular with Trump’s base.
Perspective Read More
Black Americans Are More Skeptical of a Coronavirus Vaccine
Drew Altman discusses how systemic racism has led to striking levels of reluctance to get a COVID-19 vaccine among Black Americans, including those at highest risk, and the challenge it presents for ending the pandemic.
Perspective Read More